Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Higher levels of small, dense LDL cholesterol are linked to a greater risk of heart attack in young adults.

Minoxidil can cause heart muscle damage in dogs.

Minoxidil may cause heart issues in animals and humans.

This study found that EP 2 signaling is crucial for macrophage recruitment and inflammatory regulation in the injured heart, impacting cardiac repair processes.

Dihydrotestosterone (DHT) worsens heart enlargement, and blocking it may help prevent heart issues.

This study found that heart-inspired hollow hydrogel-based scaffolds enhanced regenerative capability in osteoporotic bone defects and increased cell number when using a mechanical-assisted post-bioprinting strategy.

This study found that individuals with a nondipper blood pressure pattern had higher 24-hour urinary aldosterone levels, suggesting a possible link to heart issues.

Finasteride may reduce heart damage in rats.

Hair loss linked to higher heart disease risk in both men and women.

This study found that topical minoxidil increased heart rate and had significant effects on cardiac volumes and mass compared to placebo, but its long-term safety remains uncertain.

Higher minoxidil doses in dogs cause faster heart rate, lower blood pressure, and heart issues.

Minoxidil lowers blood pressure and increases heart efficiency, but may raise lung artery pressure in some people.

This study found that the methanolic heartwood extract of Avicennia marina significantly inhibits 5α-reductase type 1, reducing 5α-DHT production by 52% in a cell-based assay with human hair dermal papilla cells.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

Minoxidil can cause fluid buildup around the heart, so patients using it should be watched for this side effect.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

Early male hair loss might signal higher heart disease risk.

Androgenetic alopecia is not linked to higher heart disease risk.

Early hair loss might indicate diabetes and heart risks, especially in those under 45.

This presentation reviews the potential of novel device-based interventions for heart failure treatment, noting that despite advances in drug therapy, many patients still experience significant symptoms. Results of these interventions, which address limitations of medication, are not reported in this abstract.

Trichodysplasia spinulosa can occur after a heart transplant due to immunosuppressive drugs.

Female hair loss may be linked to heart health and aging.

Hair follicle stem cells can become heart muscle cells.

This article discusses advancements in heart tissue engineering, emphasizing the importance of environmental signals for cardiomyocyte survival and growth, but reports no new clinical findings.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

This study found that prototype right heart circulatory assist devices significantly improved hemodynamics and reduced pulmonary vascular resistances in piglet models of acute hemodynamic shock.

This article highlights the potential heart risks associated with the prolonged 8–10 hour duration of FUT surgeries due to extended exposure to surgical medications, but reports no new clinical findings.

This study found that the methanolic heartwood extract of Avicennia marina significantly inhibited the enzyme 5 alpha-reductase type 1 in a cell-based assay, suggesting potential anti-androgenic effects for treating androgenic alopecia.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

This study found that cardiac fibroblasts significantly enhance the maturation of neonatal mouse and human embryonic stem cell-derived cardiomyocytes, suggesting a pivotal role in postnatal heart development and disease.